PubMed Health⌕ Search

PubMed · 6886945

Colonic stricture complicating formula protein intolerance enterocolitis.

Abstract

Cases of formula protein intolerance (FPI), in which many of the features of neonatal necrotizing enterocolitis (NEC) have been exhibited (vomiting, diarrhea, hematochezia, abdominal distention, and pneumatosis intestinalis), have been reported (1-6). This case of combined cow's milk and soy protein intolerance illustrates further the difficulty in distinguishing clinically between NEC and FPI. Moreover, it demonstrates that intestinal stricture is a potential long-term complication of FPI, as it is also of NEC, and suggests that significant morbidity may result when the diagnosis of FPI is not considered as a cause of the NEC syndrome.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S J Schwarzenberg, P F Whitington. 1983. Colonic stricture complicating formula protein intolerance enterocolitis.. https://doi.org/10.1097/00005176-198302010-00026

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Crohn's disease.

Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and associated immune disorders. Genome wide association studies identified susceptibility loci that--triggered by environmental factors--result in a disturbed innate (ie, disturbed intestinal barrier, Paneth cell dysfunction, endoplasmic reticulum stress, defective unfolded protein response and autophagy, impaired recognition of microbes by pattern recognition receptors, such as nucleotide binding domain and Toll like receptors on dendritic cells and macrophages) and adaptive (ie, imbalance of effector and regulatory T cells and cytokines, migration and retention of leukocytes) immune response towards a diminished diversity of commensal microbiota. We discuss the epidemiology, immunobiology, amd natural history of Crohn's disease; describe new treatment goals and risk stratification of patients; and provide an evidence based rational approach to diagnosis (ie, work-up algorithm, new imaging methods [ie, enhanced endoscopy, ultrasound, MRI and CT] and biomarkers), management, evolving therapeutic targets (ie, integrins, chemokine receptors, cell-based and stem-cell-based therapies), prevention, and surveillance.

Colonic Diseases↗